GLPG
Price
$26.74
Change
+$0.01 (+0.04%)
Updated
Feb 21 closing price
Capitalization
1.74B
60 days until earnings call
INZY
Price
$1.25
Change
-$0.02 (-1.57%)
Updated
Feb 21 closing price
Capitalization
80.3M
26 days until earnings call
Ad is loading...

GLPG vs INZY

Header iconGLPG vs INZY Comparison
Open Charts GLPG vs INZYBanner chart's image
Galapagos
Price$26.74
Change+$0.01 (+0.04%)
Volume$286.48K
Capitalization1.74B
Inozyme Pharma
Price$1.25
Change-$0.02 (-1.57%)
Volume$705.24K
Capitalization80.3M
GLPG vs INZY Comparison Chart
Loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLPG vs. INZY commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPG is a Hold and INZY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (GLPG: $26.74 vs. INZY: $1.25)
Brand notoriety: GLPG and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLPG: 96% vs. INZY: 93%
Market capitalization -- GLPG: $1.74B vs. INZY: $80.3M
GLPG [@Biotechnology] is valued at $1.74B. INZY’s [@Biotechnology] market capitalization is $80.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLPG’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • GLPG’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, INZY is a better buy in the long-term than GLPG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLPG’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • GLPG’s TA Score: 4 bullish, 5 bearish.
  • INZY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, INZY is a better buy in the short-term than GLPG.

Price Growth

GLPG (@Biotechnology) experienced а +5.11% price change this week, while INZY (@Biotechnology) price change was -8.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

GLPG is expected to report earnings on Apr 23, 2025.

INZY is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($1.74B) has a higher market cap than INZY($80.3M). GLPG YTD gains are higher at: -2.764 vs. INZY (-54.874). GLPG has higher annual earnings (EBITDA): -63.34M vs. INZY (-90.3M). GLPG has more cash in the bank: 3.34B vs. INZY (132M). GLPG has less debt than INZY: GLPG (11.5M) vs INZY (46.8M). GLPG has higher revenues than INZY: GLPG (260M) vs INZY (0).
GLPGINZYGLPG / INZY
Capitalization1.74B80.3M2,167%
EBITDA-63.34M-90.3M70%
Gain YTD-2.764-54.8745%
P/E Ratio53.70N/A-
Revenue260M0-
Total Cash3.34B132M2,530%
Total Debt11.5M46.8M25%
FUNDAMENTALS RATINGS
GLPG: Fundamental Ratings
GLPG
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLPGINZY
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend about 1 month ago
87%
Declines
ODDS (%)
Bearish Trend 19 days ago
78%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PM154.402.83
+1.87%
Philip Morris International
SKIL27.53-0.20
-0.72%
Skillsoft Corp
ENLT17.82-0.20
-1.11%
Enlight Renewable Energy Ltd
OSUR3.80-0.08
-2.06%
OraSure Technologies
NXT46.12-2.30
-4.75%
Nextracker

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
+0.04%
VCYT - GLPG
43%
Loosely correlated
-4.56%
INZY - GLPG
39%
Loosely correlated
-1.57%
RGNX - GLPG
36%
Loosely correlated
-1.22%
MLYS - GLPG
36%
Loosely correlated
+0.31%
AXON - GLPG
35%
Loosely correlated
-5.28%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-1.57%
IGMS - INZY
51%
Loosely correlated
-0.72%
MRSN - INZY
47%
Loosely correlated
+0.98%
BEAM - INZY
45%
Loosely correlated
-8.18%
THRD - INZY
44%
Loosely correlated
-3.07%
ERAS - INZY
44%
Loosely correlated
-3.42%
More